On the public citation graph

Transcriptional control of O6‐methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma

0 signed · 64 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/cncr.30023openalex-snapshot
Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009
inferredcites →https://doi.org/10.1007/s11060-011-0749-4openalex-snapshot
Glioblastoma survival in the United States before and during the temozolomide era
inferredcites →https://doi.org/10.1016/j.bcp.2010.10.014openalex-snapshot
NFκB inhibitors induce cell death in glioblastomas
inferredcites →https://doi.org/10.1016/j.gde.2008.01.020openalex-snapshot
NF-κB and cancer — identifying targets and mechanisms
inferredcites →https://doi.org/10.1016/j.stem.2009.01.007openalex-snapshot
PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells
inferredcites →https://doi.org/10.1016/j.ymeth.2012.09.007openalex-snapshot
RT-qPCR work-flow for single-cell data analysis
inferredcites →https://doi.org/10.1016/s1470-2045(17)30194-8openalex-snapshot
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
inferredcites →https://doi.org/10.1038/nrneurol.2009.197openalex-snapshot
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
inferredcites →https://doi.org/10.1038/onc.2015.387openalex-snapshot
The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway
inferredcites →https://doi.org/10.1038/s41419-017-0051-2openalex-snapshot
Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma
inferredcites →https://doi.org/10.1038/sj.cdd.4401269openalex-snapshot
NF-κB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells
inferredcites →https://doi.org/10.1038/sj.onc.1210949openalex-snapshot
Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria
inferredcites →https://doi.org/10.1056/nejmoa043331openalex-snapshot
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
inferredcites →https://doi.org/10.1093/brain/awt025openalex-snapshot
Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells
inferredcites →https://doi.org/10.1093/neuonc/noq032openalex-snapshot
Sensitivity to temozolomide in brain tumor initiating cells
inferredcites →https://doi.org/10.1101/gad.261982.115openalex-snapshot
Cancer stem cells in glioblastoma
inferredcites →https://doi.org/10.1111/j.1471-4159.2005.03583.xopenalex-snapshot
O6‐methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells
inferredcites →https://doi.org/10.1111/j.1471-4159.2012.07781.xopenalex-snapshot
Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells
inferredcites →https://doi.org/10.1111/jnc.12802openalex-snapshot
Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?
inferredcites →https://doi.org/10.1128/mcb.24.2.823-836.2004openalex-snapshot
Distinct Domains in the SHP-2 Phosphatase Differentially Regulate Epidermal Growth Factor Receptor/NF-κB Activation through Gab1 in Glioblastoma Cells
inferredcites →https://doi.org/10.1136/ard.2006.064717openalex-snapshot
Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment
inferredcites →https://doi.org/10.1136/ard.2007.087106openalex-snapshot
Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study
inferredcites →https://doi.org/10.1158/0008-5472.can-06-3820openalex-snapshot
Novel Mechanism whereby Nuclear Factor κB Mediates DNA Damage Repair through Regulation of O 6-Methylguanine-DNA-Methyltransferase
inferredcites →https://doi.org/10.1158/0008-5472.can-06-4180openalex-snapshot
CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular Profiles
inferredcites →https://doi.org/10.1158/0008-5472.can-07-6878openalex-snapshot
Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma
inferredcites →https://doi.org/10.1158/1078-0432.ccr-10-1931openalex-snapshot
Extent and Patterns of MGMT Promoter Methylation in Glioblastoma- and Respective Glioblastoma-Derived Spheres
inferredcites →https://doi.org/10.1158/1535-7163.mct-13-0772openalex-snapshot
Interferon-β Induces Loss of Spherogenicity and Overcomes Therapy Resistance of Glioblastoma Stem Cells
inferredcites →https://doi.org/10.1186/1471-2407-9-372openalex-snapshot
Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults
inferredcites →https://doi.org/10.1186/1476-4598-5-67openalex-snapshot
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
inferredcites →https://doi.org/10.1200/jco.2005.02.9405openalex-snapshot
Tumor Necrosis Factor-α–Induced Protein 3 As a Putative Regulator of Nuclear Factor-κB–Mediated Resistance to O6-Alkylating Agents in Human Glioblastomas
inferredcites →https://doi.org/10.18632/oncotarget.7346openalex-snapshot
MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4888426openalex-extracted
Investigative Radiogenomic Analysis of Gliomas by Combining miRNA Profiles and Functional MRI
inferred← citeshttps://doi.org/10.1002/jat.3762openalex-snapshot
miR‐222/GAS5 is involved in DNA damage and cytotoxic effects induced by temozolomide in T98G cell line
inferred← citeshttps://doi.org/10.1007/978-3-031-10909-6_55openalex-snapshot
Radiomics and Radiogenomics in Glioma
inferred← citeshttps://doi.org/10.1007/s00018-021-03906-7openalex-snapshot
The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?
inferred← citeshttps://doi.org/10.1007/s11060-024-04708-0openalex-snapshot
Enhancing Temozolomide (TMZ) chemosensitivity using CRISPR-dCas9-mediated downregulation of O6-methylguanine DNA methyltransferase (MGMT)
inferred← citeshttps://doi.org/10.1016/b978-0-12-821567-8.00001-4openalex-snapshot
Role of long noncoding RNAs in temozolomide-resistant glioblastoma
inferred← citeshttps://doi.org/10.1016/j.bbadis.2023.166782openalex-snapshot
Magnolol and Temozolomide exhibit a synergistic anti-glioma activity through MGMT inhibition
inferred← citeshttps://doi.org/10.1016/j.drudis.2019.03.008openalex-snapshot
Therapy for glioblastoma: is it working?
inferred← citeshttps://doi.org/10.1016/j.fitote.2025.106607openalex-snapshot
Coumarin MAMMEA A/BB cytotoxicity inhibits the chemoresistance and migration of glioblastoma cells in vitro
inferred← citeshttps://doi.org/10.1016/j.gendis.2023.04.017openalex-snapshot
Transcriptomic analysis identifies the neuropeptide cortistatin (CORT) as an inhibitor of temozolomide (TMZ) resistance by suppressing the NF-κB-MGMT signaling axis in human glioma
inferred← citeshttps://doi.org/10.1016/j.omto.2020.12.009openalex-snapshot
Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma
inferred← citeshttps://doi.org/10.1016/j.prp.2024.155636openalex-snapshot
Recent update on anti-tumor mechanisms of valproic acid in glioblastoma multiforme
inferred← citeshttps://doi.org/10.1016/j.tranon.2018.10.002openalex-snapshot
OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth
inferred← citeshttps://doi.org/10.1038/s41598-026-36379-4openalex-snapshot
MGMT upregulation mediates Temozolomide resistance conferred USP5 dependency
inferred← citeshttps://doi.org/10.1080/1061186x.2022.2119243openalex-snapshot
Progress in research and development of temozolomide brain-targeted preparations: a review
inferred← citeshttps://doi.org/10.1098/rsif.2019.0722openalex-snapshot
Mitigating temozolomide resistance in glioblastoma via DNA damage-repair inhibition
inferred← citeshttps://doi.org/10.1111/cns.13591openalex-snapshot
Regulation of temozolomide resistance in glioma cells via the RIP2/NF‐κB/MGMT pathway
inferred← citeshttps://doi.org/10.1111/jcmm.70380openalex-snapshot
Temozolomide‐Promoted MGMT Transcription Contributes to Chemoresistance by Activating the ERK Signalling Pathway in Malignant Melanoma
inferred← citeshttps://doi.org/10.1111/jnc.14280openalex-snapshot
Outlining involvement of stem cell program in regulation of O6‐methylguanine DNA methyltransferase and development of temozolomide resistance in glioblastoma
inferred← citeshttps://doi.org/10.1186/s12935-025-03770-6openalex-snapshot
STAT3/TGFBI signaling promotes the temozolomide resistance of glioblastoma through upregulating glycolysis by inducing cellular senescence
inferred← citeshttps://doi.org/10.21037/tcr-20-3426openalex-snapshot
Cinnamophilin enhances temozolomide-induced cytotoxicity against malignant glioma: the roles of ROS and cell cycle arrest
inferred← citeshttps://doi.org/10.2174/0113892010336491241022094511openalex-snapshot
Influence of Nanomedicine as a Smart Weapon for Multidrug Resistance in Cancer Therapy
inferred← citeshttps://doi.org/10.3389/fgene.2022.1032286openalex-snapshot
The role of RNA modification in the generation of acquired drug resistance in glioma
inferred← citeshttps://doi.org/10.3389/fonc.2019.01547openalex-snapshot
O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy
inferred← citeshttps://doi.org/10.3389/fphar.2018.00873openalex-snapshot
Glycogenolysis in Acquired Glioma Resistance to Temozolomide: A Role for the [Ca2+]i-dependent Activation of Na,K-ATPase/ERK1/2 Signaling
inferred← citeshttps://doi.org/10.3389/fphar.2020.629266openalex-snapshot
DNA Repair Pathways in Cancer Therapy and Resistance
inferred← citeshttps://doi.org/10.3390/biology11010070openalex-snapshot
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines
inferred← citeshttps://doi.org/10.3390/cancers11050655openalex-snapshot
A Role for NF-κB in Organ Specific Cancer and Cancer Stem Cells
inferred← citeshttps://doi.org/10.3390/cancers13051136openalex-snapshot
Nanopore Sequencing Reveals Global Transcriptome Signatures of Mitochondrial and Ribosomal Gene Expressions in Various Human Cancer Stem-like Cell Populations
inferred← citeshttps://doi.org/10.3390/cancers15245836openalex-snapshot
Unlocking Glioblastoma Secrets: Natural Killer Cell Therapy against Cancer Stem Cells
inferred← citeshttps://doi.org/10.3390/ijms232112919openalex-snapshot
Targeting Key Signaling Pathways in Glioblastoma Stem Cells for the Development of Efficient Chemo- and Immunotherapy
inferred← citeshttps://doi.org/10.3390/ijms26167883openalex-snapshot
The Pivotal Role of NF-κB in Glioblastoma: Mechanisms of Activation and Therapeutic Implications
inferred← citeshttps://doi.org/10.37349/etat.2025.1002335openalex-snapshot
Genetic and epigenetic landscape of O6-methylguanine-DNA methyltransferase (MGMT): implications for DNA repair and cancer therapeutics
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.